Rose Venier

Rose is an ABGC and CBGC certified genetic counsellor in the Division of Clinical and Metabolic Genetics and the Genetics and Genome Biology program at SickKids. She completed her Master of Science in Genetic Counselling at the University of Pittsburgh and joined SickKids in 2021. Rose works primarily with the SickKids Cancer Sequencing (KiCS) Program, helping families understand the role of genetics in cancer and how precision oncology can inform patient care. In her clinical role,  she counsels patients and families in the Cancer Genetics Program regarding hereditary cancer predisposition syndromes. Rose is a member of Genomic Research Genetic Counsellors at SickKids.

Research

Rose is interested in how genomics informs care in oncology, not only for the patient but for their family as well. The KiCS program is a pillar of the Precision Child Health initiative at SickKids and is key in driving this work. She is also interested in the use of ancestry and ethnicity data in genomics, and understanding barriers to access genetic counselling/testing.

Education and experience

• 2021-present: Genetic Counsellor, KiCS and Cancer Genetics Programs, The Hospital for Sick Children, Toronto, ON, CAN
• 2020-2021: Genetic Counsellor, Cancer Genetics Clinic, Juravinski Cancer Centre, Hamilton, ON, CAN
• 2018-2020: MS Genetic Counseling, University of Pittsburgh, Pittsburgh, PA, USA
• 2015-2018: Laboratory Manager,  Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, CAN
• 2012-2015: Laboratory Technician, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, CAN
• 2010-2012: MSc Biology, McMaster University, Hamilton, ON, CAN
• 2006-2010: BSc Hon Molecular Biology, McMaster University, Hamilton, ON, CAN

1. Villani A., Davidson S., Kanwar N., Lo W.W., Li Y., Cohen-Gogo S., Fuligni F., Edward L.M., Light N., Layeghifard M., Harripaul R., Waldman L., Gallinger B., Comitani F., Brunga L., Hayes R., Anderson N.D., Ramani A.K., Yuki K.E., Blay S., Johnstone B., Inglese C., Hammad R., Goudie C., Shuen A., Wasserman J.D., Venier R.E., Eliou M., Lorenti M., Ryan C.A., Braga M., Gloven-Brown M., Han J., Montero M., Spatare F., Whitlock J.A., Scherer S.W., Chun K., Somerville M.J., Hawkins C., Abdelhaleem M., Ramaswamy V., Somers G.R., Kyriakopoulou L., Hitzler J., Shago M., Morgenstern D.A., Tabori U., Meyn S., Irwin M.S., Malkin D., Shlien A. The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutations. Nat Cancer. 2023 Feb;4(2):203-221. PMID: 36585449
2. Venier R.E., Grubs R.E., Kessler E., Cooper, K.L., Bailey K.M., Meade J. Evaluation of barriers to referral for cancer predisposition syndromes in pediatric oncology patients in the United States. J. Genet Couns. 2022 Aug; 31(4):901-911. PMID: 35147246
3. Venier R.E.*, Maurer L.M.*, Kessler E.M., Ranganathan S., McGough R.L., Weiss K.R., Malek M.M., Meade J., Tersak J.M., Bailey K.M. A germline BARD1 mutation in a patient with Ewing sarcoma: implications for familial testing and counseling. Pediatr Blood Cancer. 2019 Jun 3:e27824

See more publications from Rose Venier

Affiliated websites